Symbol="PSTX"
AssetType="Common Stock"
Name="Poseida Therapeutics Inc"
Description="Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for patients with high unmet medical needs. The company is headquartered in San Diego, California."
CIK="1661460"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="9390 TOWNE CENTRE DRIVE, SUITE 200, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="168344000"
EBITDA="-37212000"
PERatio="None"
PEGRatio="None"
BookValue="1.816"
DividendPerShare="0"
DividendYield="0"
EPS="-0.44"
RevenuePerShareTTM="1.79"
ProfitMargin="-0.321"
OperatingMarginTTM="-0.305"
ReturnOnAssetsTTM="-0.0946"
ReturnOnEquityTTM="-0.343"
RevenueTTM="139400000"
GrossProfitTTM="-22407000"
DilutedEPSTTM="-0.44"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="6.21"
AnalystTargetPrice="13.4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.525"
PriceToBookRatio="2.265"
EVToRevenue="1.988"
EVToEBITDA="-16.1"
Beta="0.118"
num_52WeekHigh="8.82"
num_52WeekLow="1.54"
num_50DayMovingAverage="2.451"
num_200DayMovingAverage="4.258"
SharesOutstanding="86776000"
DividendDate="None"
ExDividendDate="None"
symbol="PSTX"
open="2.00"
high="2.09"
low="1.97"
price="1.99"
volume="443817.00"
latest_trading_day="2023-07-13"
previous_close="1.95"
change="0.04"
change_percent="2.0513%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="86"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="14"
Volume_recent_avg="892878"
Change_recent_avg="-0.05"
Delta_recent_avg="0.28"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-1.57"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="14"
Aroon_momentum_negative="86"
image_negative_thumbnail_id_1="103"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0073.jpeg"
image_negative_thumbnail_id_2="520"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0085.jpeg"
image_neutral_thumbnail_id_1="523"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_neutral_thumbnail_id_2="580"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="969"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0131.jpeg"
image_positive_thumbnail_id_2="665"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0043.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
